According to a new report LAMEA Coronary stents Market, published by KBV research, the LAMEA Coronary stents Market would witness market growth of 9.9% CAGR during the forecast period (2018 – 2024).
The Brazil market dominated the LAMEA Polymer Free Coatings Market by Country in 2017. The Argentina market is expected to witness a CAGR of 10.2% during (2018 - 2024). Additionally, The UAE market is expected to witness a CAGR of 9.5% during (2018 - 2024).
The Drug-eluting stents (DES) market would dominate the LAMEA Coronary Stents Market by Product by 2024, growing at a CAGR of 9.7 % during the forecast period. The Bare-Metal Stents market is expected to witness a CAGR of 9.6% during (2018 - 2024). Additionally, The Bioresorbable Vascular Scaffold market is expected to witness highest CAGR of 12% during (2018 - 2024).
The Micro porous Surface market dominated the Nigeria Coronary Stents Market by Polymer Free Drug Eluting Stents Type in 2017, and would achieve a market value of $5.8 million by 2024. The Nanoporous Surface market is expected to witness a CAGR of 12.2% during (2018 - 2024).
Full Report: https://www.kbvresearch.com/lamea-coronary-stents-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of ABBOTT, Terumo Medical Corporation, Medtronic Plc., B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard, Inc., Cook Medical Incorporated, Johnson & Johnson, Biotronik SE & Co. KG, Biosensors International Group Ltd.
By Country
Companies Profiled
Unique Offerings from KBV Research
Related Reports:
Unique Offerings 
